Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsC5 Biotech Patenting Conference
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
C5 (UK) will be holding its 17th Forum on Biotech Patenting on October 20-21, 2009 in London, United Kingdom. The conference will allow attendees to collect up-to-date information and insights on: ? Recent changes in policy and patentability criteria: Hear directly from the EPO; ? The latest EPO decisions impacting key aspects of biotech patenting such as methods of surgery and new standards on double patenting and prior art; ? Major U.S. case law developments and how they have radically shifted the status quo for biotech, including In re Bilski, Ariad, and In re Kubin; ? The latest developments on...Full post as published by Patent Docs on August 29, 2009 (boomark / email).
Lawsuits and Settlements
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

C5 "Biotech Patenting" Conference, London, September 23-24
ACI "Biotech Patents" Conference, Boston, September 15-16
Biotech Patents: How To Face New Challenges
ACI "Pharma/Biotech IP Due Diligence" Conference, New York, January 30-31
Biotech Patents: Strategies for an Evolving Legal Climate
Upcoming Patent Events: Pharma/Biotech IP Due Diligence









